NANOG and neoplasm: To determine whether the same effect occurs in primary tumors from NPC patients, we performed an immunohistochemical analysis using antibodies against PTEN, p-AKT, β-catenin, and Nanog on a tumor tissue microarray consisting of paraffin-embedded NPC samples derived from 70 patients (Figure 4A).